RxDoctor Payments Data

Juan Duchesne, MD

Surgical Critical Care · New Orleans, LANPI 1376624213

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Prytime Medical Devices, Inc. accounts for 95.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $5,515 and has fallen 99.2% since, to $43 in 2025.

$6,774in general payments, 2019–2025

Across 23 payments — averaging $294.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prytime Medical Devices, Inc.$6K
  • Olympus America Inc.$98
  • Z-medica, LLC$55
  • Zimmer Biomet$43
  • BD$37
  • Polynovo North America LLC$31
  • plus $69 from 4 others
$189,645in research payments, 2019–2025

Across 16 payments — averaging $11,853 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$190K

What the payments were for

  • Consulting fees$551%
  • Speaking & faculty fees$3,50052%
  • Travel & lodging$2,33434%
  • Food & beverage$88513%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,774 in reported general payments places this provider in the 80th percentile of 20 surgical critical care providers in Louisiana.

See all surgical critical care providers in Louisiana

Medicare billing

Part B allowed, 2024
$10,258
Medicare patients
73
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical critical care in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →